Clinical trial · Observational
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
NCT06482957CI-TRIAL-00095463CAUSALrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sarcoma | Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (7)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Collection | Other | — | UNRESOLVED |
| Physical Activity Monitoring | Other | — | UNRESOLVED |
| Saliva Collection | Other | — | UNRESOLVED |
| Stool Collection | Other | — | UNRESOLVED |
| Surveys | Other | — | UNRESOLVED |
| Tissue collection | Other | — | UNRESOLVED |
| Urine Collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients monitor physical activity, sedentary behavior, heart rate and sleep wearing a FitBit device, undergo blood urine, stool and/or saliva sample collection, complete surveys and have medical records reviewed throughout study.
- interventionNames
- Other: Surveys
- Other: Blood Collection
- Other: Saliva Collection
- Other: Urine Collection
- Other: Stool Collection
- Other: Tissue collection
- Other: Physical Activity Monitoring
Primary outcomes (4)
- measure
- Impact of disease on adverse oncologic outcomes
- timeFrame
- Approximately six years
- description
- Medical record review of Common Terminology Criteria for Adverse Events (CTCAEs)
- measure
- Impact of treatment on adverse oncologic outcomes
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Patients at any age with a history of sarcoma, with or without evidence of a persistent disease • For pediatric patients * Parent/primary caregiver of patient * Sibling of patient aged 8 years or older
References
Publications (0)
Data not yet available
No reference posted for this study.